Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ADA 2019More DECLARE-TIMI: Robust Renal Effects of DapagliflozinA new analysis from the landmark trial with the diabetes drug dapagliflozin shows a large, robust effect on important kidney outcomes. Accumulating data support 'leading role for SGLT2 inhibitors,' in diabetes.
EAS 2019Undiagnosed FH Linked to 16-Year Life Expectancy ReductionThe high premature cardiovascular death risk in undiagnosed familial hypercholesterolemia (FH) supports the case for earlier cholesterol screening, investigators say.
CREDENCE Shifts Our Thinking About SGLT2 InhibitorsThe CREDENCE trial allows us to start thinking of SGLT2 inhibitors as drugs for preserving renal function, independent of other parameters, says Anne Peters.
Swollen Necks, Dry Mouth--What Is Going On? Through a series of short patient cases, Dr Gordon Sun illustrates common presenting symptoms and the underlying causes of salivary gland diseases.
CREDENCE Shifts Our Thinking About SGLT2 InhibitorsThe CREDENCE trial allows us to start thinking of SGLT2 inhibitors as drugs for preserving renal function, independent of other parameters, says Anne Peters.
